The role of Borrelia burgdorferi outer surface proteins

FEMS Immunology and Medical Microbiology

Volumn 66, Issue 1, 2012, Pages 1-19

  Kenedy, Melisha R ^a   Lenhart, Tiffany R ^a   Akins, Darrin R ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Borrelia; Lipoprotein; Lyme disease; Outer membrane protein; Spirochete

Indexed keywords

BACTERIAL PROTEIN; BINDING PROTEIN; BORRELIA EFFLUX SYSTEM PROTEIN C; COMPLEMENT REGULATOR ACQUIRING SURFACE PROTEIN; DECORIN; DECORIN BINDING PROTEIN A; DECORIN BINDING PROTEIN B; GLYCOSAMINOGLYCAN; LIPOPROTEIN; LYME DISEASE VACCINE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN F; OUTER SURFACE PROTEIN A; OUTER SURFACE PROTEIN B; OUTER SURFACE PROTEIN D; OUTER SURFACE PROTEIN E; PORIN; PROTEIN BAMA; PROTEIN BGP; PROTEIN P66; SURFACE LOCATED MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENOME; BACTERIAL OUTER MEMBRANE; BACTERIAL VIRULENCE; BORRELIA BURGDORFERI; DISEASE TRANSMISSION; IMMUNE SYSTEM; INFESTATION; LIFE CYCLE; LYME DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SPIROCHETE; TICK;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BORRELIA BURGDORFERI GROUP; HUMANS; IMMUNE EVASION; IXODES; MEMBRANE PROTEINS; VIRULENCE FACTORS;

EID: 84866177740     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2012.00980.x     Document Type: Article

References (194)

1. Akins DR, Porcella SF, Popova TG, Shevchenko D, Baker SI, Li M, Norgard MV & Radolf JD (1995) Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homolog. Mol Microbiol 18: 507-520.
2. Alitalo A, Meri T, Lankinen H, Seppala I, Lahdenne P, Hefty PS, Akins DR & Meri S (2002) Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs. J Immunol 169: 3847-3853.
3. Alitalo A, Meri T, Chen T et al. (2004) Lysine-dependent multipoint binding of the Borrelia burgdorferi virulence factor outer surface protein E to the C terminus of factor H. J Immunol 172: 6195-6201.
4. Alverson J, Bundle SF, Sohaskey CD, Lybecker MC & Samuels DS (2003) Transcriptional regulation of the ospAB and ospC promoters from Borrelia burgdorferi. Mol Microbiol 48: 1665-1677.
5. Antonara S, Chafel RM, LaFrance M & Coburn J (2007) Borrelia burgdorferi adhesins identified using in vivo phage display. Mol Microbiol 66: 262-276.
6. Aron L, Toth C, Godfrey HP & Cabello FC (1996) Identification and mapping of a chromosomal gene cluster of Borrelia burgdorferi containing genes expressed in vivo. FEMS Microbiol Lett 145: 309-314.
7. Bankhead T & Chaconas G (2007) The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens. Mol Microbiol 65: 1547-1558.
8. Barbour AG (1993) Linear DNA of Borrelia species and antigenic variation. Trends Microbiol 1: 236-239.
9. Barbour AG & Fish D (1993) The biological and social phenomenon of Lyme disease. Science 260: 1610-1616.
10. Barbour AG & Garon CF (1987) Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science 237: 409-411.
11. Barbour AG, Tessier SL & Todd WJ (1983) Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun 41: 795-804.
12. Barbour AG, Tessier SL & Hayes SF (1984) Variation in a major surface protein of Lyme disease spirochetes. Infect Immun 45: 94-100.
13. Barbour AG, Maupin GO, Teltow GJ, Carter CJ & Piesman J (1996) Identification of an uncultivable Borrelia species in the hard tick Amblymomma americanum: possible agent of a Lyme-like illness. J Infect Dis 173: 403-409.
14. Barcena-Uribarri I, Thein M, Sacher A, Bunikis I, Bonde M, Bergstrom S & Benz R (2010) P66 porins are present in both Lyme disease and relapsing fever spirochetes: a comparison of the biophysical properties of P66 porins from six Borrelia species. Biochim Biophys Acta 1798: 1197-1203.
15. Becker M, Bunikis J, Lade BD, Dunn JJ, Barbour AG & Lawson CL (2005) Structural investigation of Borrelia burgdorferi OspB, a bactericidal Fab target. J Biol Chem 280: 17363-17370.
16. Benach JL, Bosler EM, Hanrahan JP et al. (1983) Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 308: 740-742.
17. Bergstrom S, Bundoc VG & Barbour AG (1989) Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol Microbiol 3: 479-486.
18. Blevins JS, Hagman KE & Norgard MV (2008) Assessment of decorin-binding protein A to the infectivity of Borrelia burgdorferi in the murine models of needle and tick infection. BMC Microbiol 8: 82.
19. Bockenstedt LK, Hodzic E, Feng S, Bourell KW, de Silva A, Montgomery RR, Fikrig E, Radolf JD & Barthold SW (1997) Borrelia burgdorferi strain-specific OspC-mediated immunity in mice. Infect Immun 65: 4661-4667.
20. Bos MP, Robert V & Tommassen J (2007) Biogenesis of the Gram-negative bacterial outer membrane. Annu Rev Microbiol 61: 191-214.
21. Brissette CA, Haupt K, Barthel D, Cooley AE, Bowman A, Skerka C, Wallich R, Zipfel PF, Kraiczy P & Stevenson B (2009) Borrelia burgdorferi infection-associated surface proteins ErpP, ErpA, and ErpC bind human plasminogen. Infect Immun 77: 300-306.
22. Brooks CS, Hefty PS, Jolliff SE & Akins DR (2003) Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals. Infect Immun 71: 3371-3383.
23. Brooks CS, Vuppala SR, Jett AM, Alitalo A, Meri S & Akins DR (2005) Complement regulator-acquiring surface protein 1 imparts resistance to human serum in Borrelia burgdorferi. J Immunol 175: 3299-3308.
24. Brooks CS, Vuppala SR, Jett AM & Akins DR (2006) Identification of Borrelia burgdorferi outer surface proteins. Infect Immun 74: 296-304.
25. Brown EL, Wooten RM, Johnson BJ, Iozzo RV, Smith A, Dolan MC, Guo BP, Weis JJ & Hook M (2001) Resistance to Lyme disease in decorin-deficient mice. J Clin Invest 107: 845-852.
26. Brown EL, Kim JH, Reisenbichler ES & Hook M (2005) Multicomponent Lyme vaccine: three is not a crowd. Vaccine 23: 3687-3696.
27. Bunikis J, Noppa L & Bergstrom S (1995) Molecular analysis of a 66-kDa protein associated with the outer membrane of Lyme disease Borrelia. FEMS Microbiol Lett 131: 139-145.
28. Bunikis J, Noppa L, Ostberg Y, Barbour AG & Bergstrom S (1996) Surface exposure and species specificity of an immunoreactive domain of a 66-kilodalton outer membrane protein (P66) of the Borrelia species that cause Lyme disease. Infect Immun 64: 5111-5116.
29. Bunikis I, Denker K, Ostberg Y, Andersen C, Benz R & Bergstrom S (2008) An RND-type efflux system in Borrelia burgdorferi is involved in virulence and resistance to antimicrobial compounds. PLoS Pathog 4: e1000009.
30. Burtnick MN, Downey JS, Brett PJ, Boylan JA, Frye JG, Hoover TR & Gherardini FC (2007) Insights into the complex regulation of rpoS in Borrelia burgdorferi. Mol Microbiol 65: 277-293.
31. Bykowski T, Woodman ME, Cooley AE, Brissette CA, Brade V, Wallich R, Kraiczy P & Stevenson B (2007) Coordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete's mammal-tick infection cycle. Infect Immun 75: 4227-4236.
32. Caimano MJ, Eggers CH, Hazlett KR & Radolf JD (2004) RpoS is not central to the general stress response in Borrelia burgdorferi but does control expression of one or more essential virulence determinants. Infect Immun 72: 6433-6445.
33. Caimano MJ, Iyer R, Eggers CH, Gonzalez C, Morton EA, Gilbert MA, Schwartz I & Radolf JD (2007) Analysis of the RpoS regulon in Borrelia burgdorferi in response to mammalian host signals provides insight into RpoS function during the enzootic cycle. Mol Microbiol 65: 1193-1217.
34. Carroll JA, Garon CF & Schwan TG (1999) Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infect Immun 67: 3181-3187.
35. Carroll JA, Cordova RM & Garon CF (2000) Identification of 11 pH-regulated genes in Borrelia burgdorferi localizing to linear plasmids. Infect Immun 68: 6677-6684.
36. Casjens S, Palmer N, van Vugt R et al. (2000) A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35: 490-516.
37. Centers for Disease Control (1996) Lyme disease - United States, 1995. MMWR Morb Mortal Wkly Rep 45: 481-487.
38. Champion CI, Blanco DR, Skare JT, Haake DA, Giladi M, Foley D, Miller JN & Lovett MA (1994) A 9.0 kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection. Infect Immun 62: 2653-2661.
39. Cluss RG, Silverman DA & Stafford TR (2004) Extracellular secretion of the Borrelia burgdorferi Oms28 porin and Bgp, a glycosaminoglycan binding protein. Infect Immun 72: 6279-6286.
40. Coburn J & Cugini C (2003) Targeted mutation of the outer membrane protein P66 disrupts attachment of the Lyme disease agent, Borrelia burgdorferi, to integrin alphavbeta3. P Natl Acad Sci USA 100: 7301-7306.
41. Coburn J, Chege W, Magoun L, Bodary SC & Leong JM (1999) Characterization of a candidate Borrelia burgdorferi beta(3)-chain integrin ligand identified using a phage display library. Mol Microbiol 34: 926-940.
42. Coleman JL & Benach JL (1987) Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis. J Infect Dis 155: 756-765.
43. Coleman AS, Yang X, Kumar M, Zhang X, Promnares K, Shroder D, Kenedy MR, Anderson JF, Akins DR & Pal U(2008) Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity. PLoS ONE 3: 3010e.
44. Cordes FS, Roversi P, Kraiczy P et al. (2005) A novel fold for the factor H-binding protein BbCRASP-1 of Borrelia burgdorferi. Nat Struct Mol Biol 12: 276-277.
45. Cox DL, Akins DR, Bourell KW, Lahdenne P, Norgard MV & Radolf JD (1996) Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins. P Natl Acad Sci USA 93: 7973-7978.
46. Cugini C, Medrano M, Schwan TG & Coburn J (2003) Regulation of expression of the Borrelia burgdorferi beta(3)-chain integrin ligand, P66, in ticks and in culture. Infect Immun 71: 1001-1007.
47. D'Andrea LD & Regan L (2003) TPR proteins: the versatile helix. Trends Biochem Sci 28: 655-662.
48. de Silva AM, Telford SR, Brunet LR, Barthold SW & Fikrig E (1996) Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 183: 271-275.
49. Defoe G & Coburn J (2001) Delineation of Borrelia burgdorferi p66 sequences required for integrin alpha(IIb)beta(3) recognition. Infect Immun 69: 3455-3459.
50. Earnhart CG & Marconi RT (2007) An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences. Hum Vaccin 3: 281-289.
51. Earnhart CG, Buckles EL, Dumler JS & Marconi RT (2005) Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response. Infect Immun 73: 7869-7877.
52. Earnhart CG, Buckles EL & Marconi RT (2007) Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains. Vaccine 25: 466-480.
53. Earnhart CG, Leblanc DV, Alix KE, Desrosiers DC, Radolf JD & Marconi RT (2010) Identification of residues within ligand-binding domain 1 (LBD1) of the Borrelia burgdorferi OspC protein required for function in the mammalian environment. Mol Microbiol 76: 393-408.
54. Eggers CH, Caimano MJ & Radolf JD (2004) Analysis of promoter elements involved in the transcriptional initiation of RpoS-dependent Borrelia burgdorferi genes. J Bacteriol 186: 7390-7402.
55. Eicken C, Sharma V, Klabunde T, Owens RT, Pikas DS, Hook M & Sacchettini JC (2001) Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi. J Biol Chem 276: 10010-10015.
56. Elias AF, Bono JL, Carroll JA, Stewart P, Tilly K & Rosa P (2000) Altered stationary-phase response in a Borrelia burgdorferi rpoS mutant. J Bacteriol 182: 2909-2918.
57. Fikrig E, Barthold SW, Kantor FS & Flavell RA (1991) Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J Infect Dis 164: 1224-1227.
58. Fikrig E, Chen M, Barthold SW, Anguita J, Feng W, Telford SR III & Flavell RA (1999) Borrelia burgdorferi erpT expression in the arthropod vector and murine host. Mol Microbiol 31: 281-290.
59. Fikrig E, Feng W, Barthold SW, Telford SR III & Flavell RA (2000) Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J Immunol 164: 5344-5351.
60. Fikrig E, Pal U, Chen M, Anderson JF & Flavell RA (2004) OspB antibody prevents Borrelia burgdorferi colonization of Ixodes scapularis. Infect Immun 72: 1755-1759.
61. Fischer JR, Parveen N, Magoun L & Leong JM (2003) Decorin-binding proteins A and B confer distinct mammalian cell type-specific attachment by Borrelia burgdorferi, the Lyme disease spirochete. P Natl Acad Sci USA 100: 7307-7312.
62. Fischer JR, LeBlanc KT & Leong JM (2006) Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans. Infect Immun 74: 435-441.
63. Fraser CM, Casjens S, Huang WM et al. (1997) Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390: 580-586.
64. Fuchs R, Jauris S, Lottspeich F, Preac-Mursic V, Wilske B & Soutschek E (1992) Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22kDa protein (pC) in Escherichia coli. Mol Microbiol 6: 503-509.
65. Gentle I, Gabriel K, Beech P, Waller R & Lithgow T (2004) The Omp85 family of proteins is essential for outer membrane biogenesis in mitochondria and bacteria. J Cell Biol 164: 19-24.
66. Gentle I, Burri L & Lithgow T (2005) Molecular architecture and function of the Omp85 family of proteins. Mol Microbiol 58: 1216-1225.
67. Gilmore RD Jr, Kappel KJ, Dolan MC, Burkot TR & Johnson BJB (1996) Outer surface protein C (OspC), but not P39, is a protective immunogen against tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Infect Immun 64: 2234-2239.
68. Gilmore RD Jr, Kappel KJ & Johnson BJ (1997) Molecular characterization of a 35-kilodalton protein of Borrelia burgdorferi, an antigen of diagnostic importance in early Lyme disease. J Clin Microbiol 35: 86-91.
69. Gilmore RD, Mbow ML & Stevenson B (2001) Analysis of Borrelia burgdorferi gene expression during life cycle phases of the tick vector Ixodes scapularis. Microbes Infect 3: 799-808.
70. Gilmore RD Jr, Howison RR, Schmit VL, Nowalk AJ, Clifton DR, Nolder C, Hughes JL & Carroll JA (2007) Temporal expression analysis of the Borrelia burgdorferi paralogous gene family 54 genes BBA64, BBA65, and BBA66 during persistent infection in mice. Infect Immun 75: 2753-2764.
71. Gilmore RD JrJr, Howison RR, Dietrich G, Patton TG, Clifton DR & Carroll JA (2010) The bba64 gene of Borrelia burgdorferi, the Lyme disease agent, is critical for mammalian infection via tick bite transmission. P Natl Acad Sci USA 107: 7515-7520.
72. Grimm D, Tilly K, Byram R, Stewart PE, Krum JG, Bueschel DM, Schwan TG, Policastro PF, Elias AF & Rosa PA (2004) Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. P Natl Acad Sci USA 101: 3142-3147.
73. Guo B, Norris SJ, Rosenberg LC & Hook M (1995) Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect Immun 63: 3467-3472.
74. Guo BP, Brown EL, Dorward DW, Rosenberg LC & Hook M (1998) Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol 30: 711-723.
75. Hagman KE, Lahdenne P, Popova TG, Porcella SF, Akins DR, Radolf JD & Norgard MV (1998) Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis. Infect Immun 66: 2674-2683.
76. Hanson MS, Cassatt DR, Guo BP, Patel NK, McCarthy MP, Dorward DW & Hook M (1998) Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Infect Immun 66: 2143-2153.
77. Hartmann K, Corvey C, Skerka C et al. (2006) Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1. Mol Microbiol 61: 1220-1236.
78. He M, Boardman BK, Yan D & Yang XF (2007) Regulation of expression of the fibronectin-binding protein BBK32 in Borrelia burgdorferi. J Bacteriol 189: 8377-8380.
79. Hefty PS, Jolliff SE, Caimano MJ, Wikel SK, Radolf JD & Akins DR (2001) Regulation of OspE-related, OspF-related, and Elp lipoproteins of Borrelia burgdorferi strain 297 by mammalian host-specific signals. Infect Immun 69: 3618-3627.
80. Hefty PS, Brooks CS, Jett AM, White GL, Wikel SK, Kennedy RC & Akins DR (2002a) OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human Lyme disease patients. J Clin Microbiol 40: 4256-4265.
81. Hefty PS, Jolliff SE, Caimano MJ, Wikel SK & Akins DR (2002b) Changes in temporal and spatial patterns of outer surface lipoprotein expression generate population heterogeneity and antigenic diversity in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 70: 3468-3478.
82. Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, Lahdenne P, Seppala IJ & Meri S (2001) The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 276: 8427-8435.
83. Howe TR, Mayer LW & Barbour AG (1985) A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science 227: 645-646.
84. Howe TR, LaQuier FW & Barbour AG (1986) Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit. Infect Immun 54: 207-212.
85. Hübner A, Yang X, Nolen DM, Popova TG, Cabello FC & Norgard MV (2001) Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. P Natl Acad Sci USA 98: 12724-12729.
86. Hughes JL, Nolder CL, Nowalk AJ, Clifton DR, Howison RR, Schmit VL, Gilmore RD Jr & Carroll JA (2008) Borrelia burgdorferi surface-localized proteins expressed during persistent murine infection are conserved among diverse Borrelia spp. Infect Immun 76: 2498-2511.
87. Indest KJ, Howell JK, Jacobs MB, Scholl-Meeker D, Norris SJ & Philipp MT (2001) Analysis of Borrelia burgdorferi vlsE gene expression and recombination in the tick vector. Infect Immun 69: 7083-7090.
88. Ivanova L, Christova I, Neves V, Aroso M, Meirelles L, Brisson D & Gomes-Solecki M (2009) Comprehensive seroprofiling of sixteen B. burgdorferi OspC: implications for Lyme disease diagnostics design. Clin Immunol 132: 393-400.
89. Jauris-Heipke S, Fuchs R, Motz M, Preac-Mursic V, Schwab E, Soutschek E, Will G & Wilske B (1993) Genetic heterogeneity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi. Med Microbiol Immunol 182: 37-50.
90. Kenedy MR, Vuppala SR, Siegel C, Kraiczy P & Akins DR (2009) CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi. Infect Immun 77: 2773-2782.
91. Knowles TJ, Scott-Tucker A, Overduin M & Henderson IR (2009) Membrane protein architects: the role of the BAM complex in outer membrane protein assembly. Nat Rev Microbiol 7: 206-214.
92. Koebnik R, Locher KP & Van Gelder P (2000) Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol Microbiol 37: 239-253.
93. Kraiczy P, Skerka C, Brade V & Zipfel PF (2001) Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi. Infect Immun 69: 7800-7809.
94. Kraiczy P, Hellwage J, Skerka C, Becker H, Kirschfink M, Simon MM, Brade V, Zipfel PF & Wallich R (2004) Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem 279: 2421-2429.
95. Labandeira-Rey M & Skare JT (2001) Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Infect Immun 69: 446-455.
96. Labandeira-Rey M, Seshu J & Skare JT (2003) The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms. Infect Immun 71: 4608-4613.
97. Lam TT, Nguyen TPK, Montgomery RR, Kantor FS, Fikrig E & Flavell RA (1994) Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect Immun 62: 290-298.
98. Lane RS, Piesman J & Burgdorfer W (1991) Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe. Annu Rev Entomol 36: 587-609.
99. Lenhart TR & Akins DR (2010) Borrelia burgdorferi locus BB0795 encodes a BamA orthologue required for growth and efficient localization of outer membrane proteins. Mol Microbiol 75: 692-795.
100. Li H, Dunn JJ, Luft BJ & Lawson CL (1997) Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab. P Natl Acad Sci USA 94: 3584-3589.
101. Li X, Liu X, Beck DS, Kantor FS & Fikrig E (2006) Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect Immun 74: 3305-3313.
102. Li X, Neelakanta G, Liu X, Beck DS, Kantor FS, Fish D, Anderson JF & Fikrig E (2007) Role of outer surface protein D in the Borrelia burgdorferi life cycle. Infect Immun 75: 4237-4244.
103. Liang FT, Jacobs MB, Bowers LC & Philipp MT (2002a) An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med 195: 415-422.
104. Liang FT, Nelson FK & Fikrig E (2002b) Molecular adaptation of Borrelia burgdorferi in the murine host. J Exp Med 196: 275-280.
105. Liang FT, Brown EL, Wang T, Iozzo RV & Fikrig E (2004) Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol 165: 977-985.
106. Lovrich SD, Callister SM, Lim LC, DuChateau BK & Schell RF (1994) Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe. J Infect Dis 170: 115-121.
107. Lugtenberg B & van Alphen L (1983) Molecular architecture and functioning of the outer membrane of Escherichia coli and other Gram-negative bacteria. Biochim Biophys Acta 737: 51-115.
108. Lybecker MC & Samuels DS (2007) Temperature-induced regulation of RpoS by a small RNA in Borrelia burgdorferi. Mol Microbiol 64: 1075-1089.
109. Marconi RT, Samuels DS & Garon CF (1993) Transcriptional analyses and mapping of the ospC gene in Lyme disease spirochetes. J Bacteriol 175: 926-932.
110. Marconi RT, Samuels DS, Landry RK & Garon CF (1994) Analysis of the distribution and molecular heterogeneity of the ospD gene among the Lyme disease spirochetes: evidence for lateral gene exchange. J Bacteriol 176: 4572-4582.
111. Maruskova M & Seshu J (2008) Deletion of BBA64, BBA65, and BBA66 loci does not alter the infectivity of Borrelia burgdorferi in the murine model of Lyme disease. Infect Immun 76: 5274-5284.
112. McDowell JV, Sung SY, Labandeira-Rey M, Skare JT & Marconi RT (2001) Analysis of mechanisms associated with loss of infectivity of clonal populations of Borrelia burgdorferi B31MI. Infect Immun 69: 3670-3677.
113. McDowell JV, Wolfgang J, Senty L, Sundy CM, Noto MJ & Marconi RT (2004) Demonstration of the involvement of outer surface protein E coiled coil structural domains and higher order structural elements in the binding of infection-induced antibody and the complement-regulatory protein, factor H. J Immunol 173: 7471-7480.
114. McDowell JV, Harlin ME, Rogers EA & Marconi RT (2005) Putative coiled-coil structural elements of the BbA68 protein of Lyme disease spirochetes are required for formation of its factor H binding site. J Bacteriol 187: 1317-1323.
115. McDowell JV, Hovis KM, Zhang H, Tran E, Lankford J & Marconi RT (2006) Evidence that the BBA68 protein (BbCRASP-1) of the Lyme disease spirochetes does not contribute to factor H-mediated immune evasion in humans and other animals. Infect Immun 74: 3030-3034.
116. Metts MS, McDowell JV, Theisen M, Hansen PR & Marconi RT (2003) Analysis of the OspE determinants involved in binding of factor H and OspE-targeting antibodies elicited during Borrelia burgdorferi infection in mice. Infect Immun 71: 3587-3596.
117. Miller JC, El Hage N, Babb K & Stevenson B (2000) Borrelia burgdorferi B31 Erp proteins that are dominant immunoblot antigens of animals infected with isolate B31 are recognized by only a subset of human lyme disease patient sera. J Clin Microbiol 38: 1569-1574.
118. Miller JC, von Lackum K, Babb K, McAlister JD & Stevenson B (2003) Temporal analysis of Borrelia burgdorferi Erp protein expression throughout the mammal-tick infectious cycle. Infect Immun 71: 6943-6952.
119. Moody EK, Barker RW, White JL & Crutcher JM (1998) Ticks and tick-borne diseases in Oklahoma. J Okla State Med Assoc 91: 438-445.
120. Mulay V, Caimano M, Liveris D, Desrosiers DC, Radolf JD & Schwartz I (2007) Borrelia burgdorferi BBA74, a periplasmic protein associated with the outer membrane, lacks porin-like properties. J Bacteriol 189: 2063-2068.
121. Neelakanta G, Li X, Pal U, Liu X, Beck DS, Deponte K, Fish D, Kantor FS & Fikrig E (2007) Outer surface protein B is critical for Borrelia burgdorferi adherence and survival within Ixodes ticks. PLoS Pathog 3: e33.
122. Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67: 593-656.
123. Nikaido H & Takatsuka Y (2009) Mechanisms of RND multidrug efflux pumps. Biochim Biophys Acta 1794: 769-781.
124. Nilsson CL, Cooper HJ, Hakansson K, Marshall AG, Ostberg Y, Lavrinovicha M & Bergstrom S (2002) Characterization of the P13 membrane protein of Borrelia burgdorferi by mass spectrometry. J Am Soc Mass Spectrom 13: 295-299.
125. Noppa L, Ostberg Y, Lavrinovicha M & Bergstrom S (2001) P13, an integral membrane protein of Borrelia burgdorferi, is C-terminally processed and contains surface-exposed domains. Infect Immun 69: 3323-3334.
126. Norman MU, Moriarty TJ, Dresser AR, Millen B, Kubes P & Chaconas G (2008) Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog 4: e1000169.
127. Norris SJ, Carter CJ, Howell JK & Barbour AG (1992) Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect Immun 60: 4662-4672.
128. Ohnishi J, Piesman J & de Silva A (2001) Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. P Natl Acad Sci USA 98: 670-675.
129. Ojaimi C, Brooks C, Casjens S et al. (2003) Profiling of temperature-induced changes in Borrelia burgdorferi gene expression by using whole genome arrays. Infect Immun 71: 1689-1705.
130. Ostberg Y, Pinne M, Benz R, Rosa P & Bergstrom S (2002) Elimination of channel-forming activity by insertional inactivation of the p13 gene in Borrelia burgdorferi. J Bacteriol 184: 6811-6819.
131. Ostberg Y, Carroll JA, Pinne M, Krum JG, Rosa P & Bergstrom S (2004) Pleiotropic effects of inactivating a carboxyl-terminal protease, CtpA, in Borrelia burgdorferi. J Bacteriol 186: 2074-2084.
132. Ouyang Z, Blevins JS & Norgard MV (2008) Transcriptional interplay among the regulators Rrp2, RpoN and RpoS in Borrelia burgdorferi. Microbiology 154: 2641-2658.
133. Pal U, de Silva AM, Montgomery RR, Fish D, Anguita J, Anderson JF, Lobet Y & Fikrig E (2000) Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J Clin Invest 106: 561-569.
134. Pal U, Li X, Wang T et al. (2004a) TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell 119: 457-468.
135. Pal U, Yang X, Chen M, Bockenstedt LK, Anderson JF, Flavell RA, Norgard MV & Fikrig E (2004b) OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest 113: 220-230.
136. Parveen N & Leong J (2000) Identification of a candidate glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35: 1220-1234.
137. Parveen N, Cornell KA, Bono JL, Chamberland C, Rosa P & Leong JM (2006) Bgp, a secreted glycosaminoglycan-binding protein of Borrelia burgdorferi strain N40, displays nucleosidase activity and is not essential for infection of immunodeficient mice. Infect Immun 74: 3016-3020.
138. Pinne M, Ostberg Y, Comstedt P & Bergstrom S (2004) Molecular analysis of the channel-forming protein P13 and its paralogue family 48 from different Lyme disease Borrelia species. Microbiology 150: 549-559.
139. Pinne M, Denker K, Nilsson E, Benz R & Bergstrom S (2006) The BBA01 protein, a member of paralog family 48 from Borrelia burgdorferi, is potentially interchangeable with the channel-forming protein P13. J Bacteriol 188: 4207-4217.
140. Probert WS & Johnson BJB (1998) Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol 30: 1003-1015.
141. Probert WS, Allsup KM & LeFebvre RB (1995) Identification and characterization of a surface-exposed 66-kilodalton protein from Borrelia burgdorferi. Infect Immun 63: 1933-1939.
142. Probert WS, Kim JH, Hook M & Johnson BJ (2001) Mapping the ligand-binding region of Borrelia burgdorferi fibronectin-binding protein BBK32. Infect Immun 69: 4129-4133.
143. Purser JE & Norris SJ (2000) Correlation between plasmid content and infectivity in Borrelia burgdorferi. P Natl Acad Sci USA 97: 13865-13870.
144. Purser JE, Lawrenz MB, Caimano MJ, Howell JK, Radolf JD & Norris SJ (2003) A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host. Mol Microbiol 48: 753-764.
145. Radolf JD & Caimano MJ (2008) The long strange trip of Borrelia burgdorferi outer-surface protein C. Mol Microbiol 69: 1-4.
146. Radolf JD, Bourell KW, Akins DR, Brusca JS & Norgard MV (1994) Analysis of Borrelia burgdorferi membrane architecture by freeze-fracture electron microscopy. J Bacteriol 176: 21-31.
147. Ramamoorthi N, Narasimhan S, Pal U et al. (2005) The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436: 573-577.
148. Revel AT, Talaat AM & Norgard MV (2002) DNA microarray analysis of differential gene expression in Borrelia burgdorferi, the Lyme disease spirochete. P Natl Acad Sci USA 99: 1562-1567.
149. Revel AT, Blevins JS, Almazan C, Neil L, Kocan KM, de la Fuente J, Hagman KE & Norgard MV (2005) bptA (bbe16) is essential for the persistence of the Lyme disease spirochete, Borrelia burgdorferi, in its natural tick vector. P Natl Acad Sci USA 102: 6972-6977.
150. Sadziene A, Wilske B, Ferdows MS & Barbour AG (1993) The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun 61: 2192-2195.
151. Sadziene A, Thomas DD & Barbour AG (1995) Borrelia burgdorferi mutant lacking Osp: biological and immunological characterization. Infect Immun 63: 1573-1580.
152. Scheiblhofer S, Weiss R, Durnberger H, Mostbock S, Breitenbach M, Livey I & Thalhamer J (2003) A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses. Microbes Infect 5: 939-946.
153. Schulz GE (2002) The structure of bacterial outer membrane proteins. Biochim Biophys Acta 1565: 308-317.
154. Schulze RJ & Zuckert WR (2006) Borrelia burgdorferi lipoproteins are secreted to the outer surface by default. Mol Microbiol 59: 1473-1484.
155. Schwan TG (2003) Temporal regulation of outer surface proteins of the Lyme-disease spirochaete Borrelia burgdorferi. Biochem Soc Trans 31: 108-112.
156. Schwan TG & Piesman J (2000) Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J Clin Microbiol 38: 382-388.
157. Schwan TG, Piesman J, Golde WT, Dolan MC & Rosa PA (1995) Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. P Natl Acad Sci USA 92: 2909-2913.
158. Seshu J, Esteve-Gassent MD, Labandeira-Rey M, Kim JH, Trzeciakowski JP, Hook M & Skare JT (2006) Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi. Mol Microbiol 59: 1591-1601.
159. Shi Y, Xu Q, Seemanapalli SV, McShan K & Liang FT (2006) The dbpBA locus of Borrelia burgdorferi is not essential for infection of mice. Infect Immun 74: 6509-6512.
160. Shi Y, Xu Q, McShan K & Liang FT (2008) Both decorin-binding proteins A and B are critical for the overall virulence of Borrelia burgdorferi. Infect Immun 76: 1239-1246.
161. Sikorski RS, Boguski MS, Goebl M & Hieter P (1990) A repeating amino acid motif in CDC23 defines a family of proteins and a new relationship among genes required for mitosis and RNA synthesis. Cell 60: 307-317.
162. Skare JT, Shang ES, Foley DM, Blanco DR, Champion CI, Mirzabekov T, Sokolov Y, Kagan BL, Miller JM & Lovett MA (1995) Virulent strain associated outer membrane proteins of Borrelia burgdorferi. J Clin Invest 96: 2380-2392.
163. Skare JT, Champion CI, Mirzabekov TA, Shang ES, Blanco DR, Erdjument-bromage H, Tempst P, Kagan BL, Miller JN & Lovett MA (1996) Porin activity of the native and recombinant outer membrane protein Oms28 of Borrelia burgdorferi. J Bacteriol 178: 4909-4918.
164. Skare JT, Mirzabekov TA, Shang ES et al. (1997) The Oms66 (p66) protein is a Borrelia burgdorferi porin. Infect Immun 65: 3654-3661.
165. Sklar JG, Wu T, Gronenberg LS, Malinverni JC, Kahne D & Silhavy TJ (2007) Lipoprotein SmpA is a component of the YaeT complex that assembles outer membrane proteins in Escherichia coli. P Natl Acad Sci USA 104: 6400-6405.
166. N). J Bacteriol 189: 2139-2144.
167. Steere AC, Malawista SE, Hardin JA et al. (1977a) Erythema chronicum migrans and Lyme arthritis:the enlarging clinical spectrum. Ann Intern Med 86: 685-698.
168. Steere AC, Malawista SE, Syndman DR, Shope RE, Andiman WA, Ross MR & Steele FM (1977b) Lyme arthritis: an epidemic of oliogarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 20: 7-17.
169. Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W, Schmid GP, Johnson E & Malawista SE (1983) The spirochetal etiology of Lyme disease. N Engl J Med 308: 733-740.
170. Stevenson B, Schwan TG & Rosa PA (1995) Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 63: 4535-4539.
171. Stevenson B, Tilly K & Rosa PA (1996) A family of genes located on four separate 32-kilobase circular plasmids in Borrelia burgdorferi. J Bacteriol 178: 3508-3516.
172. Stevenson B, Bono JL, Schwan TG & Rosa PA (1998) Borrelia burgdorferi Erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria. Infect Immun 66: 2648-2654.
173. Stevenson B, El Hage N, Hines MA, Miller JC & Babb K (2002) Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect Immun 70: 491-497.
174. Stewart PE, Wang X, Bueschel DM, Clifton DR, Grimm D, Tilly K, Carroll JA, Weis JJ & Rosa PA (2006) Delineating the requirement for the Borrelia burgdorferi virulence factor OspC in the mammalian host. Infect Immun 74: 3547-3553.
175. Stewart PE, Bestor A, Cullen JN & Rosa PA (2008) A tightly regulated surface protein of Borrelia burgdorferi is not essential to the mouse-tick infectious cycle. Infect Immun 76: 1970-1978.
176. Suk K, Das S, Sun W, Jwang B, Barthold SW, Flavell RA & Fikrig E (1995) Borrelia burgdorferi genes selectively expressed in the infected host. P Natl Acad Sci USA 92: 4269-4273.
177. Szczepanski A, Furie MB, Benach JL, Lane BP & Fleit HB (1990) Interaction between Borrelia burgdorferi and endothelium in vitro. J Clin Invest 85: 1637-1647.
178. Tilly K, Krum JG, Bestor A et al. (2006) Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect Immun 74: 3554-3564.
179. Tokarz R, Anderton JM, Katona LI & Benach JL (2004) Combined effects of blood and temperature shift on Borrelia burgdorferi gene expression as determined by whole genome DNA array. Infect Immun 72: 5419-5432.
180. Voulhoux R & Tommassen J (2004) Omp85, an evolutionarily conserved bacterial protein involved in outer-membrane-protein assembly. Res Microbiol 155: 129-135.
181. Wallich R, Brenner C, Kramer MD & Simon MM (1995) Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo. Infect Immun 63: 3327-3335.
182. Wallich R, Siebers A, Jahraus O, Brenner C, Stehle T & Simon MM (2001) DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but not for resolution of Lyme disease. Infect Immun 69: 2130-2136.
183. Wang IN, Dykhuizen DE, Qiu W, Dunn JJ, Bosler EM & Luft BJ (1999) Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 151: 15-30.
184. Weening EH, Parveen N, Trzeciakowski JP, Leong JM, Hook M & Skare JT (2008) Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection. Infect Immun 76: 5694-5705.
185. Wilske B, Busch U, Fingerle V, Jauris-Heipke S, Preac Mursic V & Will G (1996) Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection 24: 208-212.
186. Wu T, Malinverni J, Ruiz N, Kim S, Silhavy TJ & Kahne D (2005) Identification of a multicomponent complex required for outer membrane biogenesis in Escherichia coli. Cell 121: 235-245.
187. Yang XF, Pal U, Alani SM, Fikrig E & Norgard MV (2004) Essential role for OspA/B in the life cycle of the Lyme disease Spirochete. J Exp Med 199: 641-648.
188. Yang XF, Lybecker MC, Pal U, Alani SM, Blevins J, Revel AT, Samuels DS & Norgard MV (2005) Analysis of the ospC regulatory element controlled by the RpoN-RpoS regulatory pathway in Borrelia burgdorferi. J Bacteriol 187: 4822-4829.
189. Yang X, Coleman AS, Anguita J & Pal U (2009) A chromosomally encoded virulence factor protects the Lyme disease pathogen against host-adaptive immunity. PLoS Pathog 5: e1000326.
190. Yang X, Lenhart TR, Kariu T, Anguita J, Akins DR & Pal U (2010) Characterization of unique regions of Borrelia burgdorferi surface-located membrane protein 1. Infect Immun 78: 4477-4487.
191. Yen MR, Peabody CR, Partovi SM, Zhai Y, Tseng YH & Saier MH (2002) Protein-translocating outer membrane porins of Gram-negative bacteria. Biochim Biophys Acta 1562: 6-31.
192. Zhang JR & Norris SJ (1998a) Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion. Infect Immun 66: 3698-3704.
193. Zhang JR & Norris SJ (1998b) Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect Immun 66: 3689-3697.
194. Zhang JR, Hardham JM, Barbour AG & Norris SJ (1997) Antigenic variation in Lyme disease Borreliae by promiscuous recombination of Vmp-like sequence cassettes. Cell 89: 275-285.